US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Apnimed

28.03

-0.5200-1.82%

Post-market: 27.58-0.4500-1.61%19:59 EDT

Volume:246.33K

Turnover:6.95M

Market Cap:1.12B

PE:-35.08

High:29.56

Open:28.60

Low:27.64

Close:28.55

52wk High:35.29

52wk Low:16.12

Shares:39.82M

Float Shares:12.00M

Volume Ratio:0.59

T/O Rate:2.05%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.7990

EPS(LYR):-23.7581

ROE:--

ROA:-36.94%

PB:-3.67

PE(LYR):-1.18

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Apnimed

Exchange:

NASDAQ

Establishment Date:

2017

Employees:

65

Office Location:

39 John F. Kennedy Street,4th Floor,Cambridge,Massachusetts,United States

Website:

http://www.apnimed.com

Zip Code:

02138

Phone:

Fax:

- -

Introduction:

Apnimed, Inc. was incorporated in June 2017 under Delaware law. The company is a late-stage clinical pharmaceutical company dedicated to discovering, developing, and commercializing novel oral therapies that address the neurobiology of sleep-related breathing disorders. Its sole clinical candidate, Oxnimbi, is an investigational fixed-dose anti-apnea neuromuscular modulator combining a novel antimuscarinic agent with a selective norepinephrine reuptake inhibitor, designed to treat obstructive sleep apnea by improving upper airway muscle activity to maintain airway patency and prevent airway collapse during sleep. The company submitted a New Drug Application to the FDA in April 2026.

Directors

Name

Position

Kevin R. Lind

Chief Executive Officer and Director

Chris Dimitropoulos

Independent Director

Gary Sender

Independent Director

Lawrence G. Miller

Director and Vice Chair

Paul Fonteyne

Independent Director

Paul Sekhri

Board Chair and Director

Shareholders

Name

Position

Kevin R. Lind

Chief Executive Officer and Director

Dennis P. Molnar

Chief Operating Officer and President

Michael Kelly

Chief Financial Officer

Barry Wohl

Chief Business Officer

Beth Weinberg

Chief Regulatory and Safety Officer

Graham Goodrich

Chief Commercial Officer

John Cronin

Chief Medical Officer

Luigi Taranto Montemurro

Chief Scientific Officer

Steven Spector

Chief Legal Officer and Head of Corporate Affairs

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/stock/APMD/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"APMD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"APMD\",,,,,undefined,":{"symbol":"APMD","market":"US","secType":"STK","nameCN":"Apnimed","latestPrice":28.03,"timestamp":1787342400000,"preClose":28.55,"halted":0,"volume":246332,"hourTrading":{"tag":"盘后","latestPrice":27.58,"preClose":28.03,"latestTime":"19:59 EDT","volume":7596,"amount":212454.87,"timestamp":1787356799532,"change":-0.45,"changeRate":-0.016054,"amplitude":0.016054},"delay":0,"changeRate":-0.018213660245183873,"floatShares":12000000,"shares":39823183,"eps":-0.799,"marketStatus":"Market Closed","change":-0.52,"latestTime":"08-21 16:00:00 EDT","open":28.6,"high":29.56,"low":27.64,"amount":6948736.033568,"amplitude":0.06725,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.799,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":0,"listingDate":1785470400000,"exchange":"NASDAQ","adjPreClose":28.55,"preHourTrading":{"tag":"盘前","latestPrice":28.95,"preClose":28.55,"latestTime":"08:19 EDT","volume":93,"amount":2692.35,"timestamp":1787314764839,"change":0.4,"changeRate":0.014011,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":27.58,"preClose":28.03,"latestTime":"19:59 EDT","volume":7596,"amount":212454.87,"timestamp":1787356799532,"change":-0.45,"changeRate":-0.016054,"amplitude":0.016054},"volumeRatio":0.590759637683797},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"APMD\",,,,,undefined,":{"symbol":"APMD","floatShares":12000000,"roa":"-36.94%","roe":"--","lyrEps":-23.758134,"volumeRatio":0.590759637683797,"shares":39823183,"dividePrice":0,"high":29.56,"amplitude":0.06725,"preClose":28.55,"low":27.64,"week52Low":16.12,"pbRate":"-3.67","psRate":"9.29","week52High":35.29,"institutionHeld":0,"latestPrice":28.03,"eps":-0.799,"divideRate":0,"volume":246332,"delay":0,"ttmEps":-0.799,"open":28.6,"prevYearClose":16,"prevWeekClose":31.75,"prevMonthClose":25,"prevQuarterClose":16,"fiveDayClose":31.75,"twentyDayClose":16,"sixtyDayClose":16},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/APMD\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"APMD\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"APMD\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/APMD\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"APMD","date":"2026-08-21","current":-35.081352,"percent":0,"low":-12.343549,"twenty":-9.895607,"median":-8.661063,"eighty":-7.942829,"high":-7.725991,"avg":-8.97211,"sd":1.217242,"marketCap":1582331874},"quantilePoints":[{"date":"2026-08-07","current":-8.661063,"twenty":-8.320585,"median":-7.986942,"eighty":-7.766377,"marketCap":1110270342},{"date":"2026-08-14","current":-8.943759,"twenty":-8.664791,"median":-8.256435,"eighty":-7.766377,"marketCap":1146509438},{"date":"2026-08-21","current":-12.343549,"twenty":-9.895607,"median":-8.661063,"eighty":-7.942829,"marketCap":1582331874}],"updateTime":1787496832567},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":573282303,"yearFounded":2017,"employeeNum":65,"address":"39 John F. Kennedy Street,4th Floor,Cambridge,Massachusetts,United States","zipCode":"02138","officePhone":"617 500 8880","fiscalYearEnd":"12-31"},"stockCompanyDetail":{"websiteUrl":"http://www.apnimed.com","stockEarnings":[{"period":"1week","weight":-0.1172},{"period":"1month","weight":0.7519},{"period":"ytd","weight":0.7519}],"compareEarnings":[{"period":"1week","weight":-0.0137},{"period":"1month","weight":0.0245},{"period":"3month","weight":0.0269},{"period":"6month","weight":0.1107},{"period":"1year","weight":0.2048},{"period":"ytd","weight":0.1229}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Apnimed, Inc. was incorporated in June 2017 under Delaware law. The company is a late-stage clinical pharmaceutical company dedicated to discovering, developing, and commercializing novel oral therapies that address the neurobiology of sleep-related breathing disorders. Its sole clinical candidate, Oxnimbi, is an investigational fixed-dose anti-apnea neuromuscular modulator combining a novel antimuscarinic agent with a selective norepinephrine reuptake inhibitor, designed to treat obstructive sleep apnea by improving upper airway muscle activity to maintain airway patency and prevent airway collapse during sleep. The company submitted a New Drug Application to the FDA in April 2026.","exchange":"NASDAQ","name":"Apnimed","nameEN":"Apnimed"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"APMD\",market:\"US\",,,undefined,":{"directors":[{"name":"Kevin R. Lind","position":"Chief Executive Officer and Director"},{"name":"Chris Dimitropoulos","position":"Independent Director"},{"name":"Gary Sender","position":"Independent Director"},{"name":"Lawrence G. Miller","position":"Director and Vice Chair"},{"name":"Paul Fonteyne","position":"Independent Director"},{"name":"Paul Sekhri","position":"Board Chair and Director"}],"executives":[{"name":"Kevin R. Lind","position":"Chief Executive Officer and Director"},{"name":"Dennis P. Molnar","position":"Chief Operating Officer and President"},{"name":"Michael Kelly","position":"Chief Financial Officer"},{"name":"Barry Wohl","position":"Chief Business Officer"},{"name":"Beth Weinberg","position":"Chief Regulatory and Safety Officer"},{"name":"Graham Goodrich","position":"Chief Commercial Officer"},{"name":"John Cronin","position":"Chief Medical Officer"},{"name":"Luigi Taranto Montemurro","position":"Chief Scientific Officer"},{"name":"Steven Spector","position":"Chief Legal Officer and Head of Corporate Affairs"}]}}}